ADAR1 Capital Management »

Four Leaf Acquisition Corp shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Four Leaf Acquisition Corp (FORLW) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Four Leaf Acquisition Corp

Tip: Access up to 7 years of quarterly data

All positions including Four Leaf Acquisition Corp held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Four Leaf Acquisition Corp by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $389 9.5k 0.04
2023-12-31 $284 9.5k 0.03

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Four Leaf Acquisition Corp

Highbridge Capital Management
CNH Partners
Schechter Investment Advisors
Periscope Capital
D. E. Shaw & Co
Polar Securities
Shaolin Capital Management
Hudson Bay Capital Management
Cowen And Company
HGC Investment Management
Wolverine Asset Management
Atw Spac Management
K2 Principal Fund
Rivernorth Capital Management
CVI Holdings

View all funds holding Four Leaf Acquisition Corp